biolab tb-500 bpc-157 & Peptides for Research BPC-157/TB-500 (10mg/20mg) for Research |
Description
Typically, before a drug can be marketed, it must pass through a series of clinical trials, in order to identify safe dosages and to determine that any positive outcomes are due to the substance itself, and not to bias in the study design
Clearly, the duration of the treatment protocol needs to be longer than one month
Researchers must observe the following precautions at all times
Wound healing and gastrointestinal effects BPC-157 research has also examined wound healing in skin and gut tissue
High concentration (20+ mg/mL): small volumes, precision critical High-concentration vials pack more drug into less liquid
28 HsiehM
